optomap® captures high-resolution 200° ultra-widefield (UWF™) retinal images, that help detect, diagnose, and treat retinal disorders and diseases such as glaucoma, diabetes, and cancer, in a single capture.  Using an Optos retinal imaging device, the process is painless, takes only seconds to capture an image, reduces patient wait times, improving patient satisfaction.

Prevent Blindness has declared February AMD Awareness month[1].  Age-related macular degeneration(AMD) is the most common cause of severe loss of eyesight among people 50 and older.

AMD affects the central vision, and with it, the ability to see fine details. With AMD, the macula, a part of the retina in damaged. In its early stages, AMD may have no signs or symptoms, so people may not suspect they have it. In advanced stages, people lose their ability to drive, to see faces, and to read smaller print. AMD by itself does not lead to complete blindness, with no ability to see. However, the loss of central vision in AMD can severely interfere with simple everyday activities

.

Make a wish come true with an Optos purchase. Get Optos off your wish list and into your practice.  We understand that an upfront purchase of an Optos device can feel daunting. But adopting advanced retinal imaging technology can start driving revenue in your practice the moment you invest.

optomap enables eyecare professionals to discover, diagnose, document, and treat ocular pathology . Recent studies suggest that UWF imaging may be suitable for diagnosing glaucoma in situations where slit-lamp biomicroscopy or digital color stereoscopy are not available. Another study also confirms that optomap has almost perfect agreement with color digital stereoscopy when assessed by a glaucoma specialist

Expanding on a past topic for OptosAdvance users looking to better utilize their software, we have now provided a new set of tips and tricks to using your mouse within OptosAdvance to get the most efficient image review process. Scroll to the bottom to download the full PDF. 

Investment in the latest retinal imaging technology is a commitment to grow your practice years into the future. Improve your bottom line and customer retention with innovations in eye care that help patients receive the best care possible. Features such as multimodality are helping to save sight with the early detection of potential disease and disorders. Advancements in eye care also reduce NHS waiting times and protect the lives of patients.

Each year, November 14th is recognized as World Diabetes Day and this year’s theme is “Education to Protect Tomorrow”. Understanding the condition is the first step towards managing and preventing it. One in 10 adults around the world currently live with diabetes, an estimated 537 million people. Almost half do not know they have it.

Optos would like to wish you all a happy and safe Halloween. To protect your vision, make sure you and your family receive an annual retinal exam that includes optomap®.

In a climate of economic uncertainty, Optometrists with independent or small practices face several business challenges. Our research has revealed three key indicators impacting customer retention and financial growth. 

Ultra-widefield multimodal imaging is an important clinical and research tool. By combining images from different modalities, clinicians can develop a detailed understanding of functional and morphologic aspects of various retinal diseases.

Optos offers multimodal imaging with all of its ultra-widefield imaging devices and has been shown to enhance pathology detection and disease management as well as improve clinic flow.